Obatala's CEO, Dr. Trivia Frazier, joined a panel during Idea Village's New Orleans Entrepreneur Week, "Enterprise Investing with Local Impact" where she discussed how the support of Ochsner Ventures has allowed Obatala to grow. She was joined on the panel by local investor Tara Hernandez, Ochsner Ventures CEO Aimee Quirk, Hampr founder Laurel Hess, and Benson Capital Partners Managing Director Mike Katz.
Obatala Sciences™ investment from Elevate Capital featured in WSJ
Obatala recently closed an investment from Elevate Capital, a Venture Capital fund based in Portland, Oregon. Yuliya Chernova of the Wall Street Journal covered the firm's announcement of a $26.0 million first close of the Elevate Fund II to enhance its efforts to support underserved minority and women entrepreneurs with early-stage funding. With Fund II now officially launched, Elevate has already lined up six investments, all of which are led by Black founders and CXOs. More information on the fund can be found on their website.
Obatala Sciences™ adds to Staff
Obatala Sciences is proud to announce that we have hired Michael Landry as our CFO & General Counsel. Michael received his JD and MBA from Tulane University and his BA in economics and philosophy from Syracuse University. Before pursuing a business career, he practiced disability and federal administrative law. Prior to joining Obatala Sciences, Michael advised health IT, pharmaceutical, and biotech startups (including Obatala) as a consultant and at the New Orleans BioInnovation Center. Michael leads Obatala Sciences’ financial and legal operations.
Obatala Sciences™ participates in Creative Destruction Lab Program
Obatala was a participant in the Creative Destruction Lab program based out of the University of Toronto's Rotman School of Management. Because of COVID-19, the program was held remotely, and Obatala was glad to continue in this prestigious accelerator program.